Ying Zhao

Ying Zhao

Auto-generated profile, based on publicly available information

Ying Zhao

Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, P.R. China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2023 in Molecular Human Reproduction
Verified
Journal Article
Closed access
PDF file
Yun ChenYun Chen
Yun Chen
CMChenyun Miao
Chenyun Miao
YZYing Zhao
Ying Zhao
LYLiuqing Yang
Liuqing Yang
RWRuye Wang
Ruye Wang
QZQin Zhang
Qin Zhang
Inflammasomes are multi-protein complexes localized within immune and non-immune cells that induce caspase activation, proinflammatory cytokine secretion, and ultimately pyroptosis—a type of cell death. Inflammasomes are involved in a variety of human diseases, especially acute or chronic inflammatory diseases. In this review, we focused on the strong correlation between the NLRP3 inflammasome and various reproductive diseases, including ovarian aging or premature ovarian insufficiency, PCOS, endometriosis, recurrent spontaneous abortion, preterm labor, pre-eclampsia, and male subfertility, as well as the multifaceted role of NLRP3 in the pathogenesis and treatment of these diseases. In addition, we provide an overview of the structure and amplification of inflammasomes. This comprehensive review demonstrates the vital role of NLRP3 inflammasome activation in human reproductive diseases together with the underlying mechanisms, offers new insights for mechanistic studies of reproduction, and provides promising possibilities for the development of drugs targeting the NLRP3 inflammasome for the treatment of reproductive disorders in the future.

13 August 2012 in Fitoterapia
Verified
Journal Article
Closed access
JTJiayi Tao
Jiayi Tao
ZJZhao Jun
Zhao Jun
YZYing Zhao
Ying Zhao
YCYanmei Cui
Yanmei Cui
WFWei-Shuo Fang
Wei-Shuo Fang

1 April 2024 in Cell Reports Physical Science
Verified
Journal Article
Open access
XXXiaoyan Xu
Xiaoyan Xu
HFHaowen Feng
Haowen Feng
YZYing Zhao
Ying Zhao
YSYunzhu Shi
Yunzhu Shi
WFWei Feng
Wei Feng
SGShifeng Guo
Shifeng Guo

8 July 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
YZYing Zhao
Ying Zhao
YCYun Chen
Yun Chen
CMChenyun Miao
Chenyun Miao
RWRuye Wang
Ruye Wang
LYLiuqing Yang
Liuqing Yang
JMJING MA
JING MA
Objective. To evaluate the effects of He’s Yangchao Recipe (HSYC) on ameliorating ovarian oxidative stress of aging mice under consecutive superovulation. Methods. An 8-month-old C57BL/6 female mouse was chosen to establish an aging model under ovarian hyperstimulation. Mice were randomly separated into four groups: R1 as the control group, R4 as the model group, NR4 with N-acetyl-L-cysteine (NAC) administration, and TR4 with HSYC administration. Oocyte collection, in vitro fertilization, and embryo culture were performed. The serum hormone levels were measured by enzyme-linked immunosorbent assays (ELISA); the reactive oxygen species (ROS) level of oocytes, the number of growing follicles, corpus luteum, ovulated oocytes, and developing embryos at each stage, along with the proportions of fragmented oocytes and abnormal mitochondria in granulosa cells (GCs) and the apoptosis rate of GCs were calculated; the mRNA and protein levels of JNK, P53, BAX were detected by real-time PCR and the Simple Western System. Results. HSYC enhanced estradiol, progesterone, and inhibin-B levels and increased growing follicle and corpus luteum and ovulated egg counts compared to the R4 group ( ), whereas it decreased the proportions of fragmented oocytes ( ); Meanwhile, embryos from mice subjected to four superovulation cycles with HSYC treated had a higher hatching potential. The ROS level of oocytes is downregulated by HSYC ( ) and the percentage of abnormal mitochondrial in ovaries of the TR4 group was also significantly declined compared to the R4 group ( ); the most TUNEL-positive cells proportion was detected in the R4 group; nevertheless, HSYC effectively attenuated this detrimental effect ( ). The mRNA and protein expressions of JNK and P53 in ovary tissues were reduced in the TR4 group while these genes were upregulated by repeated superovulation ( ). Conclusions. HSYC exerted promising effects on promoting the diminished ovarian reserve and decreased oocyte quality induced by both aging and consecutive ovarian superovulation, potentially via the ROS/JNK/p53 pathway.

28 November 2022 in Gynecological Endocrinology
Verified
Journal Article
Open access
RWRuye Wang
Ruye Wang
CMChenyun Miao
Chenyun Miao
CMChenyun Miao
Chenyun Miao
YZYing Zhao
Ying Zhao
LYLiuqing Yang
Liuqing Yang
QZQin Zhang
Qin Zhang
Objective: The effect of antioxidant supplements on glucose metabolism and lipid profiles in polycystic ovary syndrome (PCOS) remains controversial. This systematic review and meta-analysis aimed to evaluate whether antioxidant supplements improve glucose metabolism and lipid profiles in women with PCOS to provide optimal nutritional supplement advice in clinical practice. Methods: The search was conducted across multiple medical databases from inception to January 1, 2022 and performed following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. A random effects model was used to calculate the overall effects. Results: Eighteen trials (1113 participants) were included. Antioxidant supplements significantly improved insulin resistance (95% CI, −0.62, −0.30; p < 0.00001; I2 =48%), fasting insulin (95% CI, −0.80, −0.44; p < 0.00001; I2 = 48%), and fasting plasma glucose (95% CI, −0.54, −0.21; p < 0.00001; I2 = 38%) in patients with PCOS. However, antioxidant supplements were found to not improve most indices of lipid profiles in PCOS except triglyceride. Conclusions: Antioxidant supplements are an effective intervention for relieving insulin resistance but do not significantly improve lipid metabolism in women with PCOS.

1 July 2021 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
LGLiang Gu
Liang Gu
YLYangchen Liu
Yangchen Liu
HYHongxue Ye
Hongxue Ye
FGFei Gao
Fei Gao
XYXiaoxiang Yin
Xiaoxiang Yin
YTYe Tian
Ye Tian
Background: There are no standard therapeutic strategies for local lymph node (LN) recurrence after radical resection of oesophageal squamous cell carcinoma (ESCC), and prognostic risk factors remain controversial. We assessed clinical outcomes and prognostic factors of chemoradiotherapy (CRT) or radiotherapy (RT) for LN recurrence of ESCC after curative resection. Methods: A total of 117 ESCC patients with LN recurrence after radical resection receiving salvage treatment at our hospital were retrospectively reviewed from 2014 to 2017. Overall survival (OS) was estimated using the Kaplan–Meier method; clinical characteristics were assessed using the Log rank test in the univariate analysis. Multivariate prognostic analysis was performed using the Cox proportional hazard model. Results: With a median follow-up of 19 months, the 1-, 2- and 3-year OS rates were 75.2%, 40.2% and 27.4%, respectively. The median survival time (MST) was 19.0 months. On univariate analysis for OS, pathological TNM stage, number of LN metastasis, LN maximum (Max) diameter, salvage treatment mode and tumor response were significantly associated with OS (P = 0.0074, P = 0.015, P = 0.0011, P = 0.028, P < 0.000, respectively). On multivariate analysis, tumor response [Response vs No-response hazard ratio (HR), 2.43; 95% confidence interval (CI), 1.53– 3.90, P < 0.000] and LN Max diameter (≤ 28 mm vs > 28 mm HR, 2.07; 95% CI, 1.33– 3.32, P = 0.012) were independent prognostic factors. Conclusion: Salvage CRT or RT was safe and effective for treating LN recurrence after radical resection in ESCC. Patients with the small LN Max diameter (≤ 28 mm) and obtained response after salvage therapy appeared to achieve long-term OS.